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Abstract
Metastatic tumors generally exhibit aerobic glycolysis
(the Warburg effect). The advent of [18F]fluorodeoxy-
glucose positron emission tomography imaging,
coupled with recent findings linking hypoxia-inducible
factor (HIF-1A) overexpression to aggressive cancers,
has rekindled an interest in this aspect of tumor
metabolism. These studies explore the role of HIF-1A
in human breast cancer lines and its relationship to
glycolytic regulation. Here we demonstrate that, under
normal oxygen conditions, nonmetastatic cells con-
sume less glucose and express low HIF-1A, whereas
metastatic cells constitutively express high glycolysis
and HIF-1A, suggesting that dysregulation of HIF-1A
may induce the Warburg effect. This hypothesis was
tested by renormalizing HIF-1A levels in renal carci-
noma cells, leading to inhibition of aerobic glycolysis.
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Introduction
Warburg [1] first established a correlation between aggres-
sive tumor phenotypes and elevated glycolysis when he
observed that many tumors produce excessive levels of
lactic acid even in the presence of oxygen. Interest in the
regulation of tumor glycolysis was rekindled, in part, due to
thousands of [18F]fluorodeoxyglucose positron emission
tomography ([18F]FdG-PET) patient scans demonstrating
that a vast majority (>90%) of metastatic tumors are highly
glycolytic [2,3]. The glycolytic phenotype expressed in
metastatic cancers may be selected in periods of cyclic
hypoxia during early tumor growth [4]. In this model, cells
expressing constitutively high glycolysis survive bouts of
ischemia characteristic of tumor perfusion [5]. Many tumors
contain intermittently hypoxic microenvironments due to
poor perfusion from an irregular and inefficient vasculature
[6]. Furthermore, tumor hypoxia has been associated with
cancer progression and resistance to radiation and chemo-
therapies, despite the fact that high microvessel density is
also linked to poor prognosis [4,7,8]. This apparent dichot-
omy is likely explained by the observation that excessive
angiogenesis leads to vascular imbalance and poor perfu-
sion [9]. Acute hypoxia causes increased glycolysis at the
substrate level (the Pasteur effect), likely mediated through
intracellular redox balance. In contrast, chronic hypoxia can
lead to high rates of glycolysis through stabilization of a
hypoxia-inducible transcription factor, hypoxia-inducible factor
(HIF-1a).
The recent discovery and study of HIF-1a have implicated a
possible molecular mechanism for the Warburg effect in ma-
lignant tumors. First discovered by Semenza and Wang [10],
HIF-1a plays an important role in cellular responses to hypoxia
and other stresses. HIF-1a combines with HIF-1b to form a
heterodimeric transcription factor that regulates the expression
of glycolytic and angiogenic proteins. HIF-1a is constitutively
expressed and destabilized in the presence of O2 by proline
hydroxylation and is targeted for proteosomal degradation by
the von Hippel-Lindau (vH-L) ubiquitin ligase [11–15]. When
accumulated (e.g., under hypoxia), the HIF-1 complex binds
hypoxia response elements (HREs; canonically CCATG) in the
promoter region of target genes. These include enzymes
involved in glycolysis and pH regulation, such as phosphoglyc-
erate kinase (PGK) [16], glucose transporters GLUT-1 and
GLUT-3 [17,18], and carbonic anhydrase CA9 [19], as well
as growth factors involved in angiogenesis and erythropoie-
sis, such as vascular endothelial growth factor (VEGF) [18,20]
and erythropoietin (EPO) [10,21]. This is significant to the
pathophysiology of tumors, as immunohistochemistry has
shown that most metastatic cancers exhibit elevated levels of
HIF-1a [22], which may be attributed to hypoxia or upregulated
expression for survival purposes, even in a well-oxygenated
environment [4].
This communication investigates the relationship between
HIF-1a stabilization in oxygenated conditions and the Warburg
effect. We explored this by comparing glucose transport,
lactate production, HIF-1a protein, and HRE-induced tran-
script levels in metastatic (MDA-mb-435) and nonmetastatic
(MCF-7) breast cancer lines. Under a 20% oxygen atmo-
sphere (normoxia), MDA-mb-435 cells have elevated glycoly-
sis, HIF-1a, and HRE transcripts, whereas these parameters
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aremeasurably lower in MCF-7 cells. Hypoxia (V2% oxygen)
induced no change in the glycolytic phenotype in MDA-
mb-435 cells, whereas HIF-1a, HRE transcripts, and glycol-
ysis were profoundly induced in MCF-7 cells.
Controversial findings have identified MDA-mb-435 cells
with melanoma cells due to the expression of specific
melanocyte genes [23] and lack of expression of breast
cell line genes in MDA-mb-435 sublines [24]. To account
for this possible discrepancy, we also included the MDA-
mb-231 metastatic breast cell line for comparison to MCF-7
cells. We maintain the view, however, that MDA-mb-435
cells are breast epithelium cells that express melanocyte-
specific genes from possible lineage infidelity during tumor
progression [25].
Our findings were verified in examinations of a renal cell
carcinoma (RCC4) where transfection of the vH-L gene into
a vH-L–null line directly modulated HIF-1a levels. Parental
RCC4 cells functioned similarly to the MDA-mb-435 and
MDA-mb-231 lines by expressing high levels of HIF-1a and
exhibiting high glycolysis under normoxic conditions. There
was a minimal effect when these cells were switched to
hypoxia. Restoration of vH-L activity led to normalization
of the HIF-1a response. Under normoxia, RCC4/vH-L cells
demonstrated low rates of glycolysis, which subsequently
increased in hypoxia. Hence, these data implicate that
dysregulation of HIF-1a can be a causal factor in the
Warburg effect.
Materials and Methods
Cell Culture
MCF-7, MDA-mb-435, and MDA-mb-231 cells were
obtained from the American Type Culture Collection (ATCC;
Rockville, MD). The vH-L–null RCC4 (vH-L–transfected and
vector-alone ‘‘mock’’-transfected) cell lines were kindly do-
nated by Garth Powis (Arizona Cancer Center, Tuczon, AZ).
Cells were cultured in DMEM (Invitrogen, Carlsbad, CA)
supplemented with 10% fetal calf serum (Omega Scientific,
Inc., Tarzana, CA). Both RCC4 cell lines were selected and
cultured in 400 mg/ml Geneticin (G418) (Gibco, Grand Island,
NY). Exposure to hypoxia was carried out for 16 to 20 hours
in V2% O2, 93% N2, and 5% CO2 at 37jC.
Western Blot Analysis
Cells grown to approximately 80% confluence in 10-cm
culture dishes were harvested for cytoplasmic protein.
Cytoplasmic extracts were prepared according to the man-
ufacturer’s instructions included in NE-PER Nuclear and
Cytoplasmic Extraction Reagents (Pierce, Rockford, IL).
Protein concentration was assayed by Bradford assay
(Pierce). Western blot analysis was performed as described
previously [40]. Blots were probed overnight at 4jC, or
for 2 hours at ambient temperature, with a 1:250 dilution
of mouse antihuman HIF-1a (Transduction Laboratories,
Lexington, KY) and a 1:1000 dilution of goat antihuman
laminin (Santa Cruz Biotechnology, Santa Cruz, CA). Pri-
mary antibodies were followed by a 1:5000 dilution of horse-
radish peroxidase–conjugated goat antimouse or donkey
antigoat IgG secondary antibody (Santa Cruz Biotech-
nology) and developed using chemiluminescence kit
(Amersham Pharmacia, Uppsala, Sweden).
Quantitative Real-Time PCR
Cells were incubated for approximately 20 hours in V2%
O2, 93% N2, and 5% CO2 (hypoxia) or 20% O2, 75% N2, and
5% CO2 (normoxia). RNA was extracted using TRIZOL
reagent (Invitrogen). Nucleic acid purity and concentration
were measured on a spectrophotometer. Reverse tran-
scription reaction was performed using the First Strand Syn-
thesis kit (Invitrogen). Four micrograms of RNA was used in
each RT reaction, and oligo dTs were used as primers. The
cDNA was diluted with an equal part of filter-sterilized H2O.
Real-time PCR was performed with a light cycler (Cepheid,
Foster City, CA) using SYBR Green reporter dye and Plat-
inum Taq enzyme (Invitrogen). Twomicroliters of each cDNA
sample was used per reaction. Primers (Table 1) were
designed using the GCG/SeqLab http://bcf.arl.arizona.edu/
gcg.html) and Primer3 (http://www-genome.wi.mit.edu) soft-
ware. b-Actin, which was normalized between the cells lines
with 18S RNA primers (forward: atcaactttcgatggtagtcg; re-
verse: ggcacacgcagctcattg), was used as the control gene
for these experiments. Expression levels were determined
as described previously using the following formula [41]:
Relative gene expression = 2([b-actin Ct]  [target gene Ct]).
Statistical significance was determined by Student’s t test.
Glucose Uptake Assay
Replicates of cells were seeded in assay plates and
cultured in growth media to 80% confluency. For measure-
ments of hypoxic glucose uptake rates, culture plates were
transferred to a hypoxic incubator for 20 hours prior to
assay. Cells were then washed in glucose-free RPMI 1640
media supplemented with 12 mM NaHCO3. Glucose-free
wash media for cells to be assayed in hypoxia were also
treated with a 100-mM dilution of deferoxamine mesylate
(DFO) iron-chelating reagent (Sigma, St. Louis, MO). Cells
were then treated with 4 mCi of [3H]2-deoxy-D-glucose (2dG)
in RPMI 1640 media supplemented with 5.56 mM D-(+)-
glucose and 12 mM NaHCO3 and incubated in normoxia or
hypoxia. Postincubation supernatant was sampled for liquid
scintillation counting (LSC) using a 5000TD series liquid
scintillation counter (Beckman Coulter, Inc., Brea, CA). Cells
were washed three times in glucose-free media and lysed
with 0.1 N NaOH for 1 minute. A lysate fraction was sampled
for LSC. The remaining lysate was neutralized with 0.1 N
Table 1. Primer Sequences.
Gene Forward Primer (5V–3V) Reverse Primer (5V–3V)
PGK aggaagaagggaagggaaaag tcatcaaaaacccaccagc
GLUT-1 tcaatgctgatgatgaacctgct ggtgacacttcacccacataca
GLUT-3 gacagcccatgcatcatttcc gaacaaaaagccatccctcc
EPO gtcccagacaccaaagttaa aggccactgacggctttat
VEGF gtccaacatcaccatgcag gcaagtacgttcgtttaactc
CA9 ctttgaatgggcgagtgatt tctcatctgcacaaggaacg
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HCl and assayed for protein concentration using Bradford
reagent (Pierce). Statistical significance was determined by
Student’s t test.
Lactate Assay
Replicates of cells were seeded in assay plates and
cultured in growth media to 80% confluency. Cells were
washed three times with glucose-free RPMI supplemented
with 12 mM NaHCO3 and treated with RPMI 1640 media
supplemented with 5.56 mM D-(+)-glucose and 12 mM
NaHCO3 and incubated for 16 hours in either hypoxic or
normoxic conditions. The supernatant was assayed for lac-
tate concentration using a lactate reagent (Sigma). Statistical
significance was determined by Student’s t test.
Results
Expression of HIF-1–Regulated Genes
The Western blot analysis in Figure 1A illustrates that
HIF-1a levels in MCF-7 cells were low under normoxic
conditions and elevated after 20 hours in hypoxia. In
contrast, MDA-mb-435 and MDA-mb-231 cells expressed
elevated HIF-1a levels under normoxic conditions, which
increased further after incubation in hypoxia. The internal
b-actin controls exhibited no variation between normoxic
and hypoxic conditions within each cell line tested. b-Actin
expression levels differed between individual cell lines. This
was also observed in the RNA expression studies, indicating
that b-actin production in these cell lines was unaltered by
any experimental variables. To investigate whether the
HIF-1a was transcriptionally active in these cells, mRNA
was extracted fromMDA-mb-435, MDA-mb-231, and MCF-7
cells, and quantitative real-time polymerase chain reaction
(qRT-PCR) was carried out using primers designed for the
HIF-1a–inducible genes (Table 1). Results are provided in
Figure 2. Under normoxia, GLUT-1, GLUT-3, PGK, EPO,
and VEGF expressions were all increased in metastatic
lines compared to MCF-7. GLUT-1 expression levels were
three-fold higher in MDA-mb-435 and MDA-mb-231 than in
MCF-7. The greatest difference was observed in GLUT-3,
where MDA-mb-435 and MDA-mb-231 expression levels
were elevated 400-fold over MCF-7 GLUT-3 transcripts.
PGK expression levels, although significant, were only
marginally higher in MDA-mb-435 (by a factor of 2) and
MDA-mb-231 (by a factor of 1.5) compared to MCF-7. EPO
transcripts were four- to six-fold elevated in the metastatic
cells compared to MCF-7. VEGF mRNA expression was
Figure 1. HIF-1a expression and the glycolytic phenotype in MDA-mb-435, MDA-mb-231, and MCF-7 cells. (A) Western blots of HIF-1a with internal -actin
controls in MDA-mb-231, MDA-mb-435, and MCF-7 cells. Cells were exposed to hypoxia (V2% oxygen; ) or normoxia (20% oxygen; +) for 16 hours. (B)
Normoxic time course (240 minutes) of 2dG trapping in MDA-mb-435, MDA-mb-231, and MCF-7 cells. Glucose consumption rates were normalized from zero time
point values and expressed as nanomoles per milligram of protein. (C) Normoxic and hypoxic 2dG trapping rates in MDA-mb-435, MDA-mb-231, and MCF-7 cells.
Cells were grown under either normal (+) oxygen conditions (20%) or limiting () oxygen conditions (V2%) in 2dG for 60 minutes. Glucose consumption values
were normalized against normoxic uptake rate of MCF-7 cells. *Significant difference between expression of normoxia and hypoxia within each cell line ( P < .05).
(D) Normoxic and hypoxic lactate production. MDA-mb-435, MDA-mb-231, and MCF-7 cells were grown under either normal (+) oxygen conditions (20%) or limiting
() oxygen conditions (V2%) for approximately 16 hours. Lactate expression values were normalized against normoxic lactate production rate of MCF-7 cells.
*Significant difference between expression of normoxia and hypoxia within each cell line ( P < .05).
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increased by approximately three- to six-fold in the meta-
static cells over MCF-7. No differences between the cell lines
were observed for CA9 expression under normoxia. Nor-
moxic gene expression between the two metastatic cells
lines was similar in all genes tested, with the exception of
PGK where MDA-mb-435 levels were twice those observed
in MDA-mb-231.
Under hypoxia, all cells displayed significant increases in
all transcripts except EPO. Hypoxic induction of GLUT-3
(>25-fold), PGK (>6-fold), and VEGF (>17-fold) was more
dramatic in MCF-7 than induction levels observed in the
metastatic cell lines. GLUT-3, PGK, VEGF, and CA9
transcripts were significantly induced by hypoxia in MDA-
mb-435 cells. Transcript induction from hypoxia was similar
between MDA-mb-231 and MDA-mb-435. GLUT-1 expres-
sion was also significantly induced in MDA-mb-231 cells by
greater than 2.5-fold. The data from these experiments
imply that GLUT-1 expression might be inducible under hyp-
oxia in MDA-mb-435, but the results were not significant.
All cell lines appeared to have relatively similar EPO and
CA9 transcript levels under normoxia and hypoxia. These
genes may have different thresholds for HIF-1a activation
possibly due to the activity of other transcriptional activators
or repressors. Comparing HIF-1a expression and transcript
levels between cell lines demonstrates that there is no
strict correlation between transcript and HIF-1a levels, indi-
cating differential regulation of mRNA levels for these
genes in the assayed cell lines. Although not stoichiometric,
these data show that expression of HIF-1– inducible genes
is triggered by hypoxia (with the exception of EPO) to a
greater extent in MCF-7, compared to MDA-mb-435 and
MDA-mb-231 cells.
Glucose Uptake and Lactate Production in MDA-mb-435,
MDA-mb-231, and MCF-7 Cells
Rates of glycolysis were investigated in MDA-mb-435,
MDA-mb-231, and MCF-7 cells by monitoring the trapping
of 2dG. These data demonstrate that 2dG trapping in MDA-
mb-435 and MDA-mb-231 cells was significantly greater
than that of MCF-7 cells under normoxic conditions. Glu-
cose uptake rates were typically three-fold greater in MDA-
mb-435 and MDA-mb-231 cells with respect to MCF-7
(Figure 1B). Figure 1C illustrates that 2dG trapping in
MDA-mb-231 cells was not significantly different between
normoxia and hypoxia. In MDA-mb-435 cells, there was a
modest 1.4-fold increase in 2dG consumption under hyp-
oxia, whereas the rate of 2dG trapping increased by over
12-fold in MCF-7 under hypoxic conditions. These results
Figure 2. HIF-1a– inducible gene expression in MDA-mb-435, MDA-mb-231, and MCF-7 cells. Cells were incubated under normoxia (+) or hypoxia (), as
described in the Materials and Methods section, for approximately 20 hours. Quantitative RT-PCR was carried out on extracted mRNA using primers for GLUT-1,
GLUT-3, PGK, EPO, VEGF, and CA9. Ordinate values are based on standardization of target gene expression to that of -actin. *Significant difference between
expression of normoxia and hypoxia within each cell line ( P < .05).
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were consistent with those reported earlier using a nonradio-
active assay for glucose consumption [26].
Although trapping of 2dG is reflective of the changes
taking place in [18F]FdG-PET measurements, this endpoint
is regulated only by glucose transporter (GLUT-1 or GLUT-3)
and hexokinase activities and may not be indicative of overall
glycolysis. Therefore, lactate production levels were also
measured under normoxic and hypoxic conditions to deter-
mine if glycolysis was similarly affected. MDA-mb-435 cells
produced lactate at similar levels under both normoxia and
hypoxia, approximately five times the rate of MCF-7 cells
under normoxia. MCF-7 cells, the lowest-expressing line
under normoxia, significantly increased lactate production
when exposed to hypoxia (approximately 2.2-fold). Meta-
static cell line MDA-mb-231 demonstrated levels of lactate
production three times the levels observed in MCF-7 cells
under normoxia. These cells produced a small, but signifi-
cant, increase (1.1-fold) in lactic acid when introduced to
hypoxia in a manner similar to what was observed in MDA-
mb435 glucose uptake experiments. Hence, both 2dG con-
sumption and lactate production indicate that nonmetastatic
MCF-7 cells have a ‘‘normal’’ metabolic response (i.e., low
glycolysis under normoxia and a pronounced significant
increase on hypoxia). In contrast, the metastatic MDA-
mb-435 and MDA-mb-231 cells exhibited the Warburg effect
(i.e., high aerobic glycolysis). These behaviors are qualita-
tively similar to the differences in the HIF-1a levels observed
in both cell lines. Aerobic HIF-1a levels were higher in MDA-
mb-435 and MDA-mb-231 compared to MCF-7, concomitant
with higher glycolytic rates. Interestingly, HIF-1a levels in-
creased further in MDA-mb-435 and MDA-mb-231 cells
under hypoxia, without a further increase in glycolysis. This
suggests that glycolytic rates are maximally stimulated with
only moderate increases in HIF-1a, and this is consistent
with a high expression of the low Km GLUT-3 transcript. It is
also notable that HIF-1a levels in MCF-7 cells under hypoxia
were higher than those in MDA-mb-435 and MDA-mb-231
cells under normoxia, yet glycolytic rates were lower. Thus,
although these data suggest that HIF-1amight be involved in
the regulation of the Warburg effect, the correlation is not
exact and is likely to be cell type–dependent.
Glycolytic Phenotype in Renal Cell Lines Recapitulates
Findings in Breast Cell Lines
To address this question, vH-L–null renal cell carcinoma
(RCC4) cells were transfected to constitutively reexpress the
vH-L enzyme. As shown in Figure 3A, RCC4 cells expressed
elevated levels of HIF-1a under normoxia, attributable to
Figure 3. HIF-1a expression and the glycolytic phenotype in RCC4 and RCC4/vH-L cells. (A) Western blots measuring HIF-1a with internal lamin controls in RCC4
and RCC4/vH-L cells under normoxia and hypoxia. Cells were exposed to hypoxia (V2% oxygen; ) or normoxia (20% oxygen; +) for 16 hours. (B) Normoxic time
course (240 minutes) of 2dG trapping in RCC4 and RCC4/vH-L cells. Glucose consumption rates were normalized from zero time point values and expressed as
nanomoles per milligram of protein. (C) Normoxia and hypoxic 2dG trapping rates in RCC4 and RCC4/vH-L cells. RCC4 and RCC4/vH-L cells were grown under
either normal (+) oxygen conditions (20%) or limiting () oxygen conditions (V2%) in 2dG for 60 minutes. Glucose consumption values were normalized against
normoxic uptake rate of RCC4/vH-L cells. *Significant difference between expression of normoxia and hypoxia within each cell line ( P < .05). (D) Normoxic and
hypoxic lactate expression. RCC4 and RCC4/vH-L cells were grown under either normal (+) oxygen conditions (20%) or limiting () oxygen conditions (V2%) for
approximately 16 hours. Lactate expression values were normalized against normoxic lactate production rate of RCC4/vH-L cells. *Significant difference between
expression of normoxia and hypoxia within each cell line ( P < .05).
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defective vH-L activity, and this was not affected by hypoxia.
Reintroduction of vH-L activity with stable transfection re-
stored ‘‘normal’’ destabilization of HIF-1a in the presence
of oxygen, leading to low or absent levels under normoxia,
which increased dramatically after incubation under hypoxia.
These data are consistent with similar experiments per-
formed previously [11].
Under normoxic conditions, the vH-L–null RCC4 cells
exhibited 2dG trapping at an elevated rate similar to that
seen in MDA-mb-435 and MDA-mb-231 cells, whereas the
RCC4/vH-L cells demonstrated a 2dG uptake rate compa-
rable to MCF-7 cells (Figure 3B). Similar to the metastatic
cell lines, the vH-L–null RCC4 cells demonstrated no signif-
icant difference in 2dG trapping between normoxia and
hypoxia, whereas the RCC4/vH-L transfectants were more
akin to MCF-7 cells in that hypoxic glucose uptake increased
almost two-fold over normoxia (Figure 3C). In both cell lines,
lactate production rates correlated to the glucose consump-
tion results (Figure 3D) in that RCC4 cells demonstrated
higher normoxic lactate production than the vH-L transfec-
tants and did not upregulate lactate production when grown
under hypoxia, whereas a lactic acid increase was observed
in the vH-L transfectants. These findings are consistent with
a recent study wherein transfection of pancreatic cancer cell
lines with a dominant-negative HIF-1a resulted in reduced
aerobic glucose consumption [27]. In this same study, angio-
genesis was unaffected, underscoring the functional rela-
tionship between HIF-1 activity and glycolysis.
Discussion
The current study indicates a causal role for HIF-1a in
regulating glycolysis. Moreover, these data suggest that
aerobic stabilization of HIF-1a could potentially drive glycoly-
sis in tumors without dependence on a hypoxic environment.
The incidence of HIF-1a stabilization under normoxic con-
ditions in cancers is approximately 50%, as evidenced by
our survey of cancer cell lines [28]. These findings and
those in Figures 1A and 3A show that breast cancer lines
MDA-mb-435 and MDA-mb-231, U87 glioblastoma, DU145
prostate cancer, and renal cell carcinomas RCC4 and
CaKi express elevated HIF-1a under normoxic conditions.
These cell lines are aggressively metastatic. In contrast,
the more benign breast cancer MCF-7, HT-29 colon cancer,
MiaPaCa pancreatic cancer, A549 lung cancer, and BX-PC3
prostate cancers do not accumulate measurable HIF-1a
levels under normoxia. Although the cell lines exhibiting
visible HIF-1a under normoxia are more metastatic, these
data are too incomplete to imply an absolute correlation
between HIF-1a dysregulation and aggressiveness. None-
theless, within single cancers (i.e., for breast and prostate
cancers), the more aggressive cell lines (MDA-mb-435,
MDA-mb-231, and DU145, respectively) exhibit higher
levels of normoxic HIF-1a, unlike the less vigorous cell
lines (MCF-7 and BX-PC3, respectively). These data com-
plement HIF-1a immuno staining showing that metastatic
tumors were predominantly more positive compared to be-
nign tumors [22]. In addition to glycolysis, constitutive ex-
pression of HIF-1a would have other sequelae such as dys-
regulated angiogenesis because both VEGF and its receptor,
Flt-1, can be induced by HIF-1 activity [29]. Upregulation of
these angiogenic factors may play a part in morphogenesis
of chaotic vasculature, which is a hallmark of solid tumors
[30]. The high normoxic expression of VEGF and other
growth factors may be responsible for the correlation be-
tween microvessel density and tumor aggressiveness [31].
The mechanisms leading to accumulation of HIF-1a
under normoxic conditions in MDA-mb-435 and MDA-
mb-231 cells are unknown, and there are multiple possi-
bilities. As with other breast cancers, MDA-mb-435 and
MDA-mb-231 cells are unlikely to be vH-L–deficient [32], yet
they may lack other components of the vH-L–mediated deg-
radation pathway. HIF-1a accumulation could also occur by
Ras, Src, and/or Akt oncogene expression, leading to inhi-
bition of degradation or enhanced synthesis [33]. Increased
constitutive rates of expression lead to higher steady-state
HIF-1a levels even in the presence of active degradation.
For example, tyrosine kinase (pp60c-Src) transformation
leads to increased frequency of HIF-1a protein synthesis,
VEGF and PGK mRNA expression, and lactic acid produc-
tion, whereas the HIF-1a degradation pathway remained
functional [34]. Alternatively, HIF-1a stabilization could also
occur through the augmented activity of the molecular chap-
erone, Hsp90 [35,36]. Finally, the glycolytic endproduct,
pyruvate, promotes normoxic HIF-1a accumulation by pre-
venting degradation in a manner similar to hypoxia [37].
The data in this study indicate that elevated HIF-1 activity
is sufficient, but not necessary, for the Warburg effect. Other
mechanisms resulting in glycolytic induction are possible. A
recent report compared immunohistochemical staining pat-
terns to [18F]FdG uptake in a series of human tumors and
showed a higher correlation with GLUT-1 expression com-
pared to HIF-1a [38]. Hence, upregulated glucose transport
may be more closely associated with the high glycolysis of
the Warburg effect and elevated HIF-1a may be one of
numerous mechanisms used to achieve this phenotype.
The variable mechanisms used to enhance glycolysis, com-
bined with the almost uniform observation of high FdG
uptake in metastatic cancers, strongly suggest that elevated
glycolysis is not merely an epiphenomenon of underlying
molecular alterations, but is instead a key phenotype in
cancer progression [4,39].
Conclusion
Dysregulated HIF-1a is responsible for the Warburg effect
in some tumors.
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